| dc.description.abstract | The aim of this study was to investigate the effects of a commercial European Porcine Reproductive and Respiratory Syndrome (PRRS) - inactivated vaccine on health status, semen characteristics and semen fertilizing capacity in vivo of boars. In a farrow to finish farm that suffered from chronic course of PRRS, 7 donor boars (1.1-2.2 years old) were initially twice vaccinated, with a 4 weeks interval. At the same time, all gilts / sows of the herd were, also, vaccinated. Boars were monitored for abnormal clinical signs 24 h prior to 15 days after each vaccination. Ejaculates were collected 24 h prior, 24 h after and 15 days after each vaccination and the semen characteristics were evaluated. A total of 305 sows were inseminated twice with the collected semen 2 weeks prior up to 6 weeks after the 1(st) vaccination. No systemic clinical signs and significant differences in semen characteristics, except of sperm viability, were noticed. After the 1st vaccination, sperm viability increased, but this was probably due to the increase of the age of 7 boars during the trial and not due to the vaccination. All semen characteristics were decreased 24h after each vaccination, but they were not lower than the value of accepted criteria semen quality. No change was noticed in sow's fertility parameters, apart from the farrowing rate, that was not, however, of clinical importance. In conclusion, the use of a PRRSV inactivated vaccine in boars is safe and has not negative effects on health status and their semen characteristics neither on fertilizing capacity in vivo. | en |
